Form 4 for MRNA Moderna
Accepted 2024-05-29 00:00:00 ET · period of report 2024-05-24 · accession 0001127602-24-016777 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-29 | 2024-05-28 | MRNA | Mock James M | CFO | S - Sale+OE | $162.47 | -648 | 5,726 | -10% | -$105.3K |
| D | 2024-05-29 | 2024-05-24 | MRNA | Mock James M | CFO | M - OptEx | — | +1,326 | 6,374 | +26% | — |
| D | 2024-05-29 | 2024-05-24 | MRNA | Mock James M | CFO | M - OptEx | $0.00 | -1,326 | 3,978 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-28 | S | D | 648 | $162.47 | 5,726 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-24 | M | A | 1,326 | — | 6,374 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 3 | Derivative | Restricted Stock Units | 2024-05-24 | M | D | 1,326 | $0.00 | 3,978 | D | — · — to — | 1,326 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) 25% of the shares subject to this restricted stock unit award vested on May 27, 2024 with the remainder vesting in three (3) equal quarterly installments thereafter. |